202 related articles for article (PubMed ID: 27784799)
1. Furosemide Prescription During the Dry State Is a Predictor of Long-Term Survival of Stable, Optimally Medicated Patients With Systolic Heart Failure.
Sargento L; Simões AV; Longo S; Lousada N; Reis RP
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):256-263. PubMed ID: 27784799
[TBL] [Abstract][Full Text] [Related]
2. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Dini FL; Ghio S; Klersy C; Rossi A; Simioniuc A; Scelsi L; Genta FT; Cicoira M; Tavazzi L; Temporelli PL
Int J Clin Pract; 2013 Jul; 67(7):656-64. PubMed ID: 23758444
[TBL] [Abstract][Full Text] [Related]
3. Left atrial function index predicts long-term survival in stable outpatients with systolic heart failure.
Sargento L; Vicente Simões A; Longo S; Lousada N; Palma Dos Reis R
Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):119-127. PubMed ID: 27679598
[TBL] [Abstract][Full Text] [Related]
4. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
[TBL] [Abstract][Full Text] [Related]
5. Association of furosemide dose with clinical status, left ventricular dysfunction, natriuretic peptides, and outcome in clinically stable patients with chronic systolic heart failure.
Dini FL; Guglin M; Simioniuc A; Donati F; Fontanive P; Pieroni A; Orsini E; Caravelli P; Marzilli M
Congest Heart Fail; 2012; 18(2):98-106. PubMed ID: 22432556
[TBL] [Abstract][Full Text] [Related]
6. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
7. Geriatric nutritional risk index as a nutritional and survival risk assessment tool in stable outpatients with systolic heart failure.
Sargento L; Vicente Simões A; Rodrigues J; Longo S; Lousada N; Palma Dos Reis R
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):430-437. PubMed ID: 28438373
[TBL] [Abstract][Full Text] [Related]
8. Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Onitsuka H; Koyama S; Ideguchi T; Ishikawa T; Kitamura K; Nagamachi S
Medicine (Baltimore); 2019 Feb; 98(8):e14657. PubMed ID: 30813209
[TBL] [Abstract][Full Text] [Related]
9. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
[TBL] [Abstract][Full Text] [Related]
10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
11. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
Barywani S; Petzold M
Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
[TBL] [Abstract][Full Text] [Related]
13. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
[TBL] [Abstract][Full Text] [Related]
15. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Masuyama T; Tsujino T; Origasa H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Ito H
Circ J; 2012; 76(4):833-42. PubMed ID: 22451450
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell distribution width is a survival predictor beyond anemia and Nt-ProBNP in stable optimally medicated heart failure with reduced ejection fraction outpatients.
Sargento L; Simões AV; Longo S; Lousada N; Palma Dos Reis R
Clin Hemorheol Microcirc; 2017; 65(2):185-194. PubMed ID: 27716652
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular drug utilization post-implant is related to clinical outcome in heart failure patients receiving cardiac resynchronization therapy.
Bakos Z; Reitan C; Werther-Evaldsson A; Roijer A; Platonov P; Borgquist R
Cardiol J; 2017; 24(4):374-384. PubMed ID: 28198522
[TBL] [Abstract][Full Text] [Related]
18. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
[TBL] [Abstract][Full Text] [Related]
19. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Effect of the Dose of Loop Diuretic Over 5 Years in Chronic Heart Failure.
Laszczyńska O; Severo M; Friões F; Lourenço P; Silva S; Bettencourt P; Lunet N; Azevedo A
J Card Fail; 2017 Aug; 23(8):589-593. PubMed ID: 28390907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
